VITALANT: Form 990, tax year 2015
View the entire original 990 at ProPublica ↗
- Organization
- VITALANT (EIN 86-0098929)
- Tax period
- 2015-01-01 to 2015-12-31
- Filed
- 2016-11-14
- IRS object ID
- 201613199349312216
- Schema version
- 2015v2.1
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule D
- Schedule F
- Schedule G
- Schedule I
- Schedule J
- Schedule K
- Schedule L
- Schedule M
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2016-11-14T19:53:50-06:00 | ReturnTs |
| Tax Period End | 2015-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ERNST & YOUNG US LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | TWO NORTH CENTRAL AVENUE STE 2300 | AddressLine1Txt |
| City | PHOENIX | CityNm |
| State Abbreviation | AZ | StateAbbreviationCd |
| ZIP | 85004 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2015-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 860098929 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | BLOOD SYSTEMS INC | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| In Care Of | % SUSAN BARNES | InCareOfNm |
| Business Name Control | BLOO | BusinessNameControlTxt |
| Phone | 4809464201 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | PO BOX 1867 | AddressLine1Txt |
| City | SCOTTSDALE | CityNm |
| State Abbreviation | AZ | StateAbbreviationCd |
| ZIP | 85252 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | SUSAN L BARNES | PersonNm |
| Person Title | EXECUTIVE VP & CFO | PersonTitleTxt |
| Phone | 4809464201 | PhoneNum |
| Signature | 2016-11-14 | SignatureDt |
| Discuss With Paid Preparer | Yes (true) | DiscussWithPaidPreparerInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | BRENDA GRIESEMER | PreparerPersonNm |
| PTIN | P00264669 | PTIN |
| Phone | 6023223000 | PhoneNum |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2015 | TaxYr |
| Build TS | 2017-02-10 21:41:12Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | J DANIEL CONNOR | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | SAME AS C ABOVE | AddressLine1Txt |
| City | SCOTTSDALE | CityNm |
| State Abbreviation | AZ | StateAbbreviationCd |
| ZIP | 85252 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $772,736,486 | GrossReceiptsAmt |
| Group Return For Affiliates | false | GroupReturnForAffiliatesInd |
| Group Exemption | 6167 | GroupExemptionNum |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | www.bloodsystems.org | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1943 | FormationYr |
| Legal Domicile State | AZ | LegalDomicileStateCd |
| Activity Or Mission | BLOOD BANKING, PLASMA DERIVATIVE DISTRIBUTION, AND RESEARCH | ActivityOrMissionDesc |
| Voting Members Governing Body | 19 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 19 | VotingMembersIndependentCnt |
| Total Employee | 2877 | TotalEmployeeCnt |
| Total Volunteers | 1100 | TotalVolunteersCnt |
| Total Gross UBI | $171,758,981 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $785,626 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $8,365,565 | PYContributionsGrantsAmt |
| CY Contributions Grants | $7,622,066 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $488,666,748 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $578,648,022 | CYProgramServiceRevenueAmt |
| PY Investment Income | $5,190,677 | PYInvestmentIncomeAmt |
| CY Investment Income | $48,639,119 | CYInvestmentIncomeAmt |
| PY Other Revenue | -$128,815 | PYOtherRevenueAmt |
| CY Other Revenue | $4,991,255 | CYOtherRevenueAmt |
| PY Total Revenue | $502,094,175 | PYTotalRevenueAmt |
| CY Total Revenue | $639,900,462 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $235,610 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $226,593 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $176,835,161 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $171,596,686 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $0 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $350,819,704 | PYOtherExpensesAmt |
| CY Other Expenses | $437,305,133 | CYOtherExpensesAmt |
| PY Total Expenses | $527,890,475 | PYTotalExpensesAmt |
| CY Total Expenses | $609,128,412 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | -$25,796,300 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $30,772,050 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $401,630,955 | TotalAssetsBOYAmt |
| Total Assets EOY | $382,520,351 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $200,115,938 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $192,026,029 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $201,515,017 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $190,494,322 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | SEE SCHEDULE O | MissionDesc |
| Significant New Program Srvc | Yes (true) | SignificantNewProgramSrvcInd |
| Significant Change | false | SignificantChangeInd |
| Expense | $259,056,955 | ExpenseAmt |
| Grant | $226,593 | GrantAmt |
| Revenue | $255,156,634 | RevenueAmt |
| Desc | UNITED BLOOD SERVICES BLOOD BANKING - SEE SCHEDULE O | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $293,562,436 | ExpenseAmt |
| Grant | $0 | GrantAmt |
| Revenue | $304,884,979 | RevenueAmt |
| Desc | BIOCARE BIOLOGICALS - SEE SCHEDULE O | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $16,112,696 | ExpenseAmt |
| Grant | $0 | GrantAmt |
| Revenue | $15,625,732 | RevenueAmt |
| Desc | BLOOD SYSTEMS RESEARCH INSTITUTE - SEE SCHEDULE O | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Other Prog Srvc Expense | $12,150,300 | TotalOtherProgSrvcExpenseAmt |
| Total Other Prog Srvc Grant | $0 | TotalOtherProgSrvcGrantAmt |
| Total Other Prog Srvc Revenue | $8,067,289 | TotalOtherProgSrvcRevenueAmt |
| Total Program Service Expenses | $580,882,387 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (true) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (true) | ScheduleBRequiredInd |
| Political Campaign Acty | false | PoliticalCampaignActyInd |
| Lobbying Activities | false | LobbyingActivitiesInd |
| Subject To Proxy Tax | false | SubjectToProxyTaxInd |
| Donor Advised Fund | false | DonorAdvisedFundInd |
| Conservation Easements | false | ConservationEasementsInd |
| Collections Of Art | false | CollectionsOfArtInd |
| Credit Counseling | false | CreditCounselingInd |
| Temp Or Permanent Endowments | Yes (true) | TempOrPermanentEndowmentsInd |
| Report Land Building Equipment | Yes (true) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | false | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | false | ReportProgramRelatedInvstInd |
| Report Other Assets | false | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (true) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (true) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | false | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | Yes (true) | ConsolidatedAuditFinclStmtInd |
| School Operating | false | SchoolOperatingInd |
| Foreign Office | false | ForeignOfficeInd |
| Foreign Activities | Yes (true) | ForeignActivitiesInd |
| More Than5000 K To Org | false | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | false | MoreThan5000KToIndividualsInd |
| Professional Fundraising | false | ProfessionalFundraisingInd |
| Fundraising Activities | Yes (true) | FundraisingActivitiesInd |
| Gaming Activities | false | GamingActivitiesInd |
| Operate Hospital | false | OperateHospitalInd |
| Grants To Organizations | Yes (true) | GrantsToOrganizationsInd |
| Grants To Individuals | false | GrantsToIndividualsInd |
| Schedule J Required | Yes (true) | ScheduleJRequiredInd |
| Tax Exempt Bonds | Yes (true) | TaxExemptBondsInd |
| Invest Tax Exempt Bonds | false | InvestTaxExemptBondsInd |
| Escrow Account | false | EscrowAccountInd |
| On Behalf Of Issuer | false | OnBehalfOfIssuerInd |
| Engaged In Excess Benefit Trans | false | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | false | PYExcessBenefitTransInd |
| Loan Outstanding | Yes (true) | LoanOutstandingInd |
| Grant To Related Person | false | GrantToRelatedPersonInd |
| Business Rln With Org Mem | false | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | Yes (true) | BusinessRlnWithFamMemInd |
| Business Rln With Officer Ent | false | BusinessRlnWithOfficerEntInd |
| Deductible Non Cash Contri | Yes (true) | DeductibleNonCashContriInd |
| Deductible Art Contribution | false | DeductibleArtContributionInd |
| Terminate Operations | false | TerminateOperationsInd |
| Partial Liquidation | false | PartialLiquidationInd |
| Disregarded Entity | false | DisregardedEntityInd |
| Related Entity | Yes (true) | RelatedEntityInd |
| Related Organization Ctrl Ent | Yes (true) | RelatedOrganizationCtrlEntInd |
| Transaction With Control Ent | Yes (true) | TransactionWithControlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | false | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | false | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (true) | ScheduleORequiredInd |
| IRP Document | 462 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (true) | BackupWthldComplianceInd |
| Employee | 2877 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (true) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | Yes (true) | UnrelatedBusIncmOverLimitInd |
| Form990 T Filed | Yes (true) | Form990TFiledInd |
| Foreign Financial Account | Yes (true) | ForeignFinancialAccountInd |
| Foreign Country | CJ | ForeignCountryCd |
| Prohibited Tax Shelter Trans | false | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | false | TaxablePartyNotificationInd |
| Nondeductible Contributions | false | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | Yes (true) | QuidProQuoContributionsInd |
| Quid Pro Quo Contri Discl | Yes (true) | QuidProQuoContriDisclInd |
| Form8282 Property Disposed Of | false | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | false | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | false | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | false | IndoorTanningServicesInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 19 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 19 | IndependentVotingMemberCnt |
| Family Or Business Rln | false | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | false | DelegationOfMgmtDutiesInd |
| Change To Org Documents | false | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | false | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | false | MembersOrStockholdersInd |
| Election Of Board Members | false | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | false | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (true) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (true) | MinutesOfCommitteesInd |
| Officer Mailing Address | false | OfficerMailingAddressInd |
| Local Chapters | Yes (true) | LocalChaptersInd |
| Policies Reference Chapters | Yes (true) | PoliciesReferenceChaptersInd |
| Form990 Provided To Gvrn Body | Yes (true) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (true) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (true) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (true) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (true) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (true) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (true) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (true) | CompensationProcessOtherInd |
| Investment In Joint Venture | Yes (true) | InvestmentInJointVentureInd |
| Written Policy Or Procedure | Yes (true) | WrittenPolicyOrProcedureInd |
| States Where Copy Of Return Is Fld | AZ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CA | StatesWhereCopyOfReturnIsFldCd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | SUSAN BARNES | PersonNm |
| Phone | 4806755696 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 6210 E OAK STREET | AddressLine1Txt |
| City | SCOTTSDALE | CityNm |
| State Abbreviation | AZ | StateAbbreviationCd |
| ZIP | 85257 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part VII | Yes (X) | InfoInScheduleOPartVIIInd |
Form990 Part VII Section A Form990PartVIISectionAGrp (48 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | OfficerOfficerInd | Key EmployeeKeyEmployeeInd | Highest Compensated EmployeeHighestCompensatedEmployeeInd | Former Ofcr Director TrusteeFormerOfcrDirectorTrusteeInd |
|---|---|---|---|---|---|---|---|---|---|---|
| HEATHER ALLEN MD | ||||||||||
| TRUSTEE | 3.0 | 0.0 | Yes (X) | $26,000 | $0 | $0 | ||||
| James R Allen MD | ||||||||||
| Trustee | 3.0 | 0.0 | Yes (X) | $24,000 | $0 | $0 | ||||
| Linda Blessing PhD | ||||||||||
| Trustee | 3.0 | 1.0 | Yes (X) | $30,250 | $0 | $0 | ||||
| William A Dittman MD | ||||||||||
| Trustee | 2.0 | 1.0 | Yes (X) | $21,000 | $0 | $0 | ||||
| Armando B Flores | ||||||||||
| Trustee | 5.0 | 1.0 | Yes (X) | $23,500 | $0 | $0 | ||||
| Bill Gates | ||||||||||
| Trustee | 2.0 | 0.0 | Yes (X) | $17,000 | $0 | $0 | ||||
| William G Green | ||||||||||
| Trustee | 2.0 | 0.0 | Yes (X) | $26,500 | $0 | $0 | ||||
| Michael C Jensen | ||||||||||
| Trustee | 2.0 | 0.0 | Yes (X) | $21,000 | $0 | $0 | ||||
| F Leonard Johnson MD | ||||||||||
| Trustee | 2.0 | 0.0 | Yes (X) | $18,000 | $0 | $0 | ||||
| John Lewis | ||||||||||
| Trustee/Chair | 3.0 | 1.0 | Yes (X) | $50,750 | $0 | $0 | Yes (X) | |||
| Pierre Noel MD | ||||||||||
| Trustee | 2.0 | 0.0 | Yes (X) | $23,000 | $0 | $0 | ||||
| James Peterson | ||||||||||
| Trustee (AS OF 4/15) | 2.0 | 0.0 | Yes (X) | $16,000 | $0 | $0 | ||||
| Kathleen S Pushor | ||||||||||
| Trustee | 3.0 | 0.0 | Yes (X) | $23,250 | $0 | $0 | ||||
| Antonio Ruiz | ||||||||||
| Trustee (thru 11/15) | 2.0 | 1.0 | Yes (X) | $18,000 | $0 | $0 | ||||
| Mark T Schieble | ||||||||||
| Trustee | 2.0 | 1.0 | Yes (X) | $21,000 | $0 | $0 | ||||
| Steven L Seiler | ||||||||||
| Trustee (thru 4/15) | 3.0 | 0.0 | Yes (X) | $5,250 | $0 | $0 | ||||
| Richard G Spurlock | ||||||||||
| Trustee | 2.0 | 0.0 | Yes (X) | $21,000 | $0 | $0 | ||||
| Paul E Stander MD | ||||||||||
| Trustee | 2.0 | 0.0 | Yes (X) | $20,000 | $0 | $0 | ||||
| Ron Waeckerlin MD | ||||||||||
| Trustee/Vice Chair | 3.0 | 1.0 | Yes (X) | $36,000 | $0 | $0 | Yes (X) | |||
| Gary K Wilde | ||||||||||
| Trustee/Secretary/Treasurer | 3.0 | 1.0 | Yes (X) | $25,250 | $0 | $0 | Yes (X) | |||
| Nancy L Wollen | ||||||||||
| Trustee (as of 11/15) | 2.0 | 1.0 | Yes (X) | $0 | $0 | $0 | ||||
| J Daniel Connor | ||||||||||
| President/CEO | 38.0 | 2.0 | $672,854 | $0 | $39,344 | Yes (X) | ||||
| Susan Barnes | ||||||||||
| Executive VP and CFO | 30.0 | 20.0 | $716,067 | $0 | $21,092 | Yes (X) | ||||
| David Green | ||||||||||
| Pres Blood Centers Division | 40.0 | 0.0 | $513,262 | $0 | $38,317 | Yes (X) | ||||
| Bhavi Shah | ||||||||||
| EVP/General Counsel | 30.0 | 10.0 | $242,326 | $0 | $24,425 | Yes (X) | ||||
| Ralph Vassallo | ||||||||||
| EVP Chief Med & Scient Offcr | 40.0 | 0.0 | $469,132 | $0 | $13,833 | Yes (X) | ||||
| Mary Beth Bassett | ||||||||||
| EVP Chief Quality Officer | 40.0 | 0.0 | $436,023 | $0 | $35,518 | Yes (X) | ||||
| Michael Busch MD | ||||||||||
| SVP Research & Scientific Prog | 40.0 | 0.0 | $423,100 | $0 | $38,845 | Yes (X) | ||||
| Tom Choi | ||||||||||
| VP Inv Mngmt & Hosp Srvcs | 40.0 | 0.0 | $211,784 | $0 | $12,687 | Yes (X) | ||||
| Vicki Finson | ||||||||||
| VP Corporate Integration | 40.0 | 0.0 | $224,204 | $0 | $18,497 | Yes (X) | ||||
| Dennis Harpool | ||||||||||
| SVP Oper Policies & Processes | 40.0 | 0.0 | $229,445 | $0 | $20,775 | Yes (X) | ||||
| Robert Hartmann | ||||||||||
| VP Info Technology | 40.0 | 0.0 | $241,477 | $0 | $23,306 | Yes (X) | ||||
| Hany Kamel MD | ||||||||||
| VP Corporate Medical Director | 40.0 | 0.0 | $340,865 | $0 | $46,142 | Yes (X) | ||||
| Linda Matthews | ||||||||||
| President BioCARE | 40.0 | 0.0 | $485,472 | $0 | $44,963 | Yes (X) | ||||
| PETER MICHAELSON | ||||||||||
| VP HUMAN RESOURCES | 40.0 | 0.0 | $275,975 | $0 | $42,437 | Yes (X) | ||||
| Connie L Morris | ||||||||||
| VP Manufacturing & Lab Srvs | 40.0 | 0.0 | $180,532 | $0 | $20,480 | Yes (X) | ||||
| Phillip Norris | ||||||||||
| VP Research & Scientific Prog | 40.0 | 0.0 | $259,474 | $0 | $41,056 | Yes (X) | ||||
| Frank Nizzi MD | ||||||||||
| VP Clinical Services | 40.0 | 0.0 | $330,851 | $0 | $20,741 | Yes (X) | ||||
| Paula Villalobos | ||||||||||
| VP Field Operations | 40.0 | 0.0 | $234,534 | $0 | $12,591 | Yes (X) | ||||
| Charles E Wilcox III | ||||||||||
| VP Ops/Blood Centers Division | 40.0 | 0.0 | $263,394 | $0 | $20,688 | Yes (X) | ||||
| Kevin Land MD | ||||||||||
| Sr Medical Director | 40.0 | 0.0 | $320,414 | $0 | $20,567 | Yes (X) | ||||
| Andrew Kirk | ||||||||||
| vp sales | 40.0 | 0.0 | $281,984 | $0 | $32,785 | Yes (X) | ||||
| pedro cano MD | ||||||||||
| sr medical DIR (thru 12/2015) | 40.0 | 0.0 | $277,433 | $0 | $8,917 | Yes (X) | ||||
| ROBIN CUSICK | ||||||||||
| CHIEF MEDICAL OFFICER | 40.0 | 0.0 | $272,590 | $0 | $30,661 | Yes (X) | ||||
| MARY TOWNSEND MD | ||||||||||
| SR MEDICAL DIRECTOR | 40.0 | 0.0 | $272,349 | $0 | $33,256 | Yes (X) | ||||
| Patrick Holt | ||||||||||
| EVP Business Services | 40.0 | 0.0 | $358,730 | $0 | $0 | Yes (X) | ||||
| SALLY CAGLIOTI | ||||||||||
| PRESIDENT CTS | 0.0 | 40.0 | $0 | $1,089,016 | $36,623 | Yes (X) | ||||
| EUGENE Robertson PHD | ||||||||||
| VICE PRESIDENT CTS | 0.0 | 0.0 | $0 | $195,212 | $34,206 | Yes (X) | ||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $9,001,021 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $1,284,228 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $732,752 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 200 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | Yes (true) | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (true) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | false | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt |
|---|---|---|---|---|---|
| Manpower Inc | |||||
| 21271 NETWORK PLace | CHICAGO | IL | 60673 | CONSULTANT | $2,247,096 |
| mak systems | |||||
| 2720 river road suite 225 | DES PLAINES | IL | 60018 | CONSULTANT | $1,710,824 |
| aerotek | |||||
| 2689 collections center way | CHICAGO | IL | 60693 | CONSULTANT | $1,353,849 |
| TOLIN MECHANICAL SYSTEMS COMPANY | |||||
| 12005 EAST 45TH AVENUE | DENVER | CO | 80239 | MAINTENANCE SERVICE | $1,181,359 |
| Federal Express | |||||
| PO Box 7221 | PASADENA | CA | 91109 | DELIVERY SERVICE | $1,071,651 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 49 | CntrctRcvdGreaterThan100KCnt |
| Info In Schedule O Part VIII | Yes (X) | InfoInScheduleOPartVIIIInd |
| Federated Campaigns | $5,576 | FederatedCampaignsAmt |
| Fundraising | $130,716 | FundraisingAmt |
| Related Organizations | $2,041,311 | RelatedOrganizationsAmt |
| All Other Contributions | $5,444,463 | AllOtherContributionsAmt |
| Noncash Contributions | $5,294,229 | NoncashContributionsAmt |
| Total Contributions | $7,622,066 | TotalContributionsAmt |
Program Service Revenue ProgramServiceRevenueGrp (5 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt | Unrelated Business RevenueUnrelatedBusinessRevenueAmt |
|---|---|---|---|---|
| PHARMACEUTICAL SALES | 446110 | $305,092,002 | $133,333,021 | $171,758,981 |
| BLOOD AND COMPONENTS SERVICE FEES | 541900 | $235,845,924 | $235,845,924 | |
| PLASMA FOR FRACTIONATION | 541900 | $12,791,492 | $12,791,492 | |
| LABORATORY SERVICES | 621500 | $12,623,283 | $12,623,283 | |
| RESEARCH CONTRACTS | 541700 | $10,718,774 | $10,718,774 |
Total Oth Program Service Rev TotalOthProgramServiceRevGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $1,576,547 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $1,576,547 | RelatedOrExemptFuncIncomeAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $578,648,022 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $3,211,529 | TotalRevenueColumnAmt |
| Exclusion | $3,211,529 | ExclusionAmt |
Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Royalties Revenue RoyaltiesRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $21,020 | TotalRevenueColumnAmt |
| Exclusion | $21,020 | ExclusionAmt |
Rental Income Or Loss RentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $0 | RealAmt |
| Personal | $0 | PersonalAmt |
Net Rental Income Or Loss NetRentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $178,138,226 | SecuritiesAmt |
| Other | -$18,797 | OtherAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $132,691,839 | SecuritiesAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $45,446,387 | SecuritiesAmt |
| Other | -$18,797 | OtherAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $45,427,590 | TotalRevenueColumnAmt |
| Exclusion | $45,427,590 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Fundraising Gross Income | $27,808 | FundraisingGrossIncomeAmt |
| Contri Rpt Fundraising Event | $130,716 | ContriRptFundraisingEventAmt |
| Fundraising Direct Expenses | $144,185 | FundraisingDirectExpensesAmt |
Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -$116,377 | TotalRevenueColumnAmt |
| Exclusion | -$116,377 | ExclusionAmt |
Net Income From Gaming NetIncomeFromGamingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Net Income Or Loss NetIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Other Revenue Misc OtherRevenueMiscGrp (2 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt |
|---|---|---|---|
| MISCELLANEOUS INCOME | 900099 | $3,827,077 | $3,827,077 |
| NON-OPERATING MISCELLANEOUS INCOME | 900099 | $1,259,535 | $1,259,535 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $5,086,612 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $639,900,462 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $411,975,653 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $171,758,981 | UnrelatedBusinessRevenueAmt |
| Exclusion | $48,543,762 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $226,593 | TotalAmt |
| Program Services | $226,593 | ProgramServicesAmt |
Grants To Domestic Individuals GrantsToDomesticIndividualsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Benefits To Members BenefitsToMembersGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $7,279,713 | TotalAmt |
| Management And General | $7,279,713 | ManagementAndGeneralAmt |
Comp Disqual Persons CompDisqualPersonsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $506,438 | TotalAmt |
| Program Services | $89,686 | ProgramServicesAmt |
| Management And General | $416,752 | ManagementAndGeneralAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $125,061,605 | TotalAmt |
| Program Services | $107,310,387 | ProgramServicesAmt |
| Management And General | $17,751,218 | ManagementAndGeneralAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $9,283,416 | TotalAmt |
| Program Services | $10,647,772 | ProgramServicesAmt |
| Management And General | -$1,364,356 | ManagementAndGeneralAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $20,657,955 | TotalAmt |
| Program Services | $16,348,051 | ProgramServicesAmt |
| Management And General | $4,309,904 | ManagementAndGeneralAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $8,807,559 | TotalAmt |
| Program Services | $6,740,552 | ProgramServicesAmt |
| Management And General | $2,067,007 | ManagementAndGeneralAmt |
Fees For Services Management FeesForServicesManagementGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $665,633 | TotalAmt |
| Management And General | $665,633 | ManagementAndGeneralAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $500,983 | TotalAmt |
| Management And General | $500,983 | ManagementAndGeneralAmt |
Fees For Services Lobbying FeesForServicesLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Prof Fundraising FeesForServicesProfFundraising
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $117,887 | TotalAmt |
| Management And General | $117,887 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,204,746 | TotalAmt |
| Program Services | $1,312,227 | ProgramServicesAmt |
| Management And General | $2,892,519 | ManagementAndGeneralAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $174,352 | TotalAmt |
| Program Services | $174,352 | ProgramServicesAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $16,601,386 | TotalAmt |
| Program Services | $12,634,089 | ProgramServicesAmt |
| Management And General | $3,967,297 | ManagementAndGeneralAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,738,277 | TotalAmt |
| Program Services | $9,025,124 | ProgramServicesAmt |
| Management And General | -$5,286,847 | ManagementAndGeneralAmt |
Royalties RoyaltiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $12,353,916 | TotalAmt |
| Program Services | $11,156,867 | ProgramServicesAmt |
| Management And General | $1,197,049 | ManagementAndGeneralAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $11,381,128 | TotalAmt |
| Program Services | $9,048,813 | ProgramServicesAmt |
| Management And General | $2,332,315 | ManagementAndGeneralAmt |
Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Interest InterestGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,863,717 | TotalAmt |
| Program Services | $1,142 | ProgramServicesAmt |
| Management And General | $1,862,575 | ManagementAndGeneralAmt |
Payments To Affiliates PaymentsToAffiliatesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $14,690,688 | TotalAmt |
| Program Services | $6,440,972 | ProgramServicesAmt |
| Management And General | $8,249,716 | ManagementAndGeneralAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,234,238 | TotalAmt |
| Program Services | $876,489 | ProgramServicesAmt |
| Management And General | $357,749 | ManagementAndGeneralAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt |
|---|---|---|
| PHARM. PRODUCTS PURCHASED | $286,890,074 | $286,890,074 |
| OPERATING & TESTING SUPPLIES | $76,880,957 | $76,880,957 |
| DONOR RECOGNITION & PROMO | $9,787,803 | $9,787,803 |
| INCOME TAX | $35,950 | $35,950 |
All Other Expenses AllOtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | -$3,816,602 | TotalAmt |
| Program Services | $15,254,487 | ProgramServicesAmt |
| Management And General | -$19,071,089 | ManagementAndGeneralAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $609,128,412 | TotalAmt |
| Program Services | $580,882,387 | ProgramServicesAmt |
| Management And General | $28,246,025 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | -$8,639,484 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $126,392,934 | BOYAmt |
| EOY | $87,351,623 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $80,644,268 | BOYAmt |
| EOY | $122,779,113 | EOYAmt |
Receivables From Officers Etc ReceivablesFromOfficersEtcGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $150,000 | BOYAmt |
| EOY | $125,000 | EOYAmt |
Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $6,863,645 | BOYAmt |
| EOY | $5,983,051 | EOYAmt |
Inventories For Sale Or Use InventoriesForSaleOrUseGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $61,649,285 | BOYAmt |
| EOY | $69,301,188 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $8,842,694 | BOYAmt |
| EOY | $6,527,770 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $205,420,753 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $139,306,659 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $79,235,672 | BOYAmt |
| EOY | $66,114,094 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $27,081,572 | BOYAmt |
| EOY | $25,097,431 | EOYAmt |
Investments Other Securities InvestmentsOtherSecuritiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $9,290,011 | BOYAmt |
| EOY | $6,743,105 | EOYAmt |
Investments Program Related InvestmentsProgramRelatedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Intangible Assets IntangibleAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $480,000 | BOYAmt |
| EOY | $360,000 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,000,874 | BOYAmt |
| EOY | $777,460 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $401,630,955 | BOYAmt |
| EOY | $382,520,351 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $106,814,464 | BOYAmt |
| EOY | $107,239,610 | EOYAmt |
Grants Payable GrantsPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $26,175,000 | BOYAmt |
| EOY | $23,620,000 | EOYAmt |
Escrow Account Liability EscrowAccountLiabilityGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Loans From Officers Directors LoansFromOfficersDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $23,417,911 | BOYAmt |
| EOY | $16,014,465 | EOYAmt |
Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $43,708,563 | BOYAmt |
| EOY | $45,151,954 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $200,115,938 | BOYAmt |
| EOY | $192,026,029 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows SFAS117 | Yes (X) | OrganizationFollowsSFAS117Ind |
Unrestricted Net Assets UnrestrictedNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $201,515,017 | BOYAmt |
| EOY | $190,494,322 | EOYAmt |
Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $201,515,017 | BOYAmt |
| EOY | $190,494,322 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $401,630,955 | BOYAmt |
| EOY | $382,520,351 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part XI | Yes (X) | InfoInScheduleOPartXIInd |
| Reconcilation Revenue Expnss | $30,772,050 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | -$50,846,004 | NetUnrlzdGainsLossesInvstAmt |
| Donated Services And Use Fclts | $847,773 | DonatedServicesAndUseFcltsAmt |
| Other Changes In Net Assets | $8,205,486 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | false | AccountantCompileOrReviewInd |
| FS Audited | Yes (true) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Consolidated Basis Fincl Stmt | Yes (X) | ConsolidatedBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (true) | AuditCommitteeInd |
| Federal Grant Audit Required | Yes (true) | FederalGrantAuditRequiredInd |
| Federal Grant Audit Performed | Yes (true) | FederalGrantAuditPerformedInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Publicly Supported Org509a2 | Yes (X) | PubliclySupportedOrg509a2Ind |
Gifts Grants Contris Rcvd509 GiftsGrantsContrisRcvd509Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $7,850,022 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $9,272,139 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $8,382,904 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $8,365,565 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $7,622,066 | CurrentTaxYearAmt |
| Total | $41,492,696 | TotalAmt |
Gross Receipts Admissions GrossReceiptsAdmissionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $485,095,730 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $483,844,494 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $476,310,348 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $488,608,480 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $583,584,663 | CurrentTaxYearAmt |
| Total | $2,517,443,715 | TotalAmt |
Gross Receipts Non Unrlt Bus GrossReceiptsNonUnrltBusGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Tax Rev Levied Orgnztnl Bnft509 TaxRevLeviedOrgnztnlBnft509Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Govt Furn Srvc Fclts Vl509 GovtFurnSrvcFcltsVl509Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Total509 Total509Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $492,945,752 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $493,116,633 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $484,693,252 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $496,974,045 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $591,206,729 | CurrentTaxYearAmt |
| Total | $2,558,936,411 | TotalAmt |
Amounts Rcvd Dsqlfy Person AmountsRcvdDsqlfyPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Substantial Contributors Amt SubstantialContributorsAmtGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Subst And Dsqlfy Prsns Tot SubstAndDsqlfyPrsnsTotGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Support Total509 | $2,558,936,411 | PublicSupportTotal509Amt |
Gross Investment Income509 GrossInvestmentIncome509Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $4,163,810 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $3,987,530 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $3,621,490 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $4,295,796 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $3,232,549 | CurrentTaxYearAmt |
| Total | $19,301,175 | TotalAmt |
Post1975 UBTI Post1975UBTIGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $15,544 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $47,343 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $67,686 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $47,439 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $74,585 | CurrentTaxYearAmt |
| Total | $252,597 | TotalAmt |
Investment Income And UBTI InvestmentIncomeAndUBTIGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $4,179,354 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $4,034,873 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $3,689,176 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $4,343,235 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $3,307,134 | CurrentTaxYearAmt |
| Total | $19,553,772 | TotalAmt |
Net Income From Other UBI NetIncomeFromOtherUBIGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Other Income509 OtherIncome509Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Total Support Calendar Year TotalSupportCalendarYearGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $497,125,106 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $497,151,506 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $488,382,428 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $501,317,280 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $594,513,863 | CurrentTaxYearAmt |
| Total | $2,578,490,183 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Support CY509 | 0.99242 | PublicSupportCY509Pct |
| Public Support PY509 | 0.99226 | PublicSupportPY509Pct |
| Investment Income CY | 0.00758 | InvestmentIncomeCYPct |
| Investment Income PY | 0.00773 | InvestmentIncomePYPct |
| Thirty Thr Pct Suprt Tests CY509 | Yes (X) | ThirtyThrPctSuprtTestsCY509Ind |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule D IRS990ScheduleD
| Field | Value | IRS element (for citing) |
|---|---|---|
| Art Public Exhibition Amounts | ArtPublicExhibitionAmountsGrp | |
| Held Works Art | HeldWorksArtGrp |
CY Endwmt Fund CYEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $26,960,483 | BeginningYearBalanceAmt |
| Contributions | $483 | ContributionsAmt |
| Investment Earnings Or Losses | -$561,129 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $1,302,406 | OtherExpendituresAmt |
| End Year Balance | $25,097,431 | EndYearBalanceAmt |
CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $29,650,105 | BeginningYearBalanceAmt |
| Investment Earnings Or Losses | $1,268,538 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $3,958,160 | OtherExpendituresAmt |
| End Year Balance | $26,960,483 | EndYearBalanceAmt |
CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $27,010,166 | BeginningYearBalanceAmt |
| Investment Earnings Or Losses | $3,712,762 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $1,072,823 | OtherExpendituresAmt |
| End Year Balance | $29,650,105 | EndYearBalanceAmt |
CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $25,294,973 | BeginningYearBalanceAmt |
| Investment Earnings Or Losses | $2,769,261 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $1,044,881 | OtherExpendituresAmt |
| Administrative Expenses | $9,187 | AdministrativeExpensesAmt |
| End Year Balance | $27,010,166 | EndYearBalanceAmt |
CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $21,171,221 | BeginningYearBalanceAmt |
| Contributions | $4,060,473 | ContributionsAmt |
| Investment Earnings Or Losses | $68,277 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $0 | OtherExpendituresAmt |
| Administrative Expenses | $4,998 | AdministrativeExpensesAmt |
| End Year Balance | $25,294,973 | EndYearBalanceAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Board Designated Balance EOY | 1.00000 | BoardDesignatedBalanceEOYPct |
| Prmnnt Endowment Balance EOY | 0.00000 | PrmnntEndowmentBalanceEOYPct |
| Term Endowment Balance EOY | 0.00000 | TermEndowmentBalanceEOYPct |
| Endowments Held Unrelated Org | false | EndowmentsHeldUnrelatedOrgInd |
| Endowments Held Related Org | false | EndowmentsHeldRelatedOrgInd |
Land LandGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Investment Cost Or Other Basis | $0 | InvestmentCostOrOtherBasisAmt |
| Other Cost Or Other Basis | $6,802,117 | OtherCostOrOtherBasisAmt |
| Book Value | $6,802,117 | BookValueAmt |
Buildings BuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Investment Cost Or Other Basis | $0 | InvestmentCostOrOtherBasisAmt |
| Other Cost Or Other Basis | $62,013,050 | OtherCostOrOtherBasisAmt |
| Depreciation | $40,160,406 | DepreciationAmt |
| Book Value | $21,852,644 | BookValueAmt |
Leasehold Improvements LeaseholdImprovementsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Investment Cost Or Other Basis | $0 | InvestmentCostOrOtherBasisAmt |
| Other Cost Or Other Basis | $14,003,819 | OtherCostOrOtherBasisAmt |
| Depreciation | $12,510,239 | DepreciationAmt |
| Book Value | $1,493,580 | BookValueAmt |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Investment Cost Or Other Basis | $0 | InvestmentCostOrOtherBasisAmt |
| Other Cost Or Other Basis | $69,647,071 | OtherCostOrOtherBasisAmt |
| Depreciation | $57,807,724 | DepreciationAmt |
| Book Value | $11,839,347 | BookValueAmt |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Investment Cost Or Other Basis | $0 | InvestmentCostOrOtherBasisAmt |
| Other Cost Or Other Basis | $52,954,696 | OtherCostOrOtherBasisAmt |
| Depreciation | $28,828,290 | DepreciationAmt |
| Book Value | $24,126,406 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $66,114,094 | TotalBookValueLandBuildingsAmt |
| Federal Income Tax Liability | $0 | FederalIncomeTaxLiabilityAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp (3 entries)
| DescDesc | AmtAmt |
|---|---|
| CURRENT LINE OF CREDIT | $45,000,000 |
| LONG TERM RENT STEP UP | $147,296 |
| LT TENANT IMPROVEMENT ALLOWANCE | $4,658 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $45,151,954 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| SCHEDULE D, PART V, LINE 4 | THE BLOOD SYSTEMS BOARD RESTRICTED ENDOWMENT FUNDS ARE RESERVED FOR THE PURPOSES OF PROVIDING RESEARCH FUNDS TO BLOOD SYSTEMS RESEARCH INSTITUTE TO SUPPORT THE BLOOD TRANSFUSION RESEARCH EFFORTS OF THAT DIVISION. |
| SCHEDULE D, PART X, LINE 2 | AT DECEMBER 31, 2015, THE COMPANY EVALUATED WHETHER IT HAD UNCERTAIN TAX POSITIONS THAT SHOULD BE RECOGNIZED OR DERECOGNIZED BASED ON A 'MORE LIKELY THAN NOT' THRESHOLD FOR TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN, INCLUDING THOSE TAX POSITIONS THAT WOULD NOT BE SUSTAINED UPON EXAMINATION IN ACCORDANCE WITH GUIDANCE RELATED TO ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES. THE TAX YEARS FOR THE COMPANY THAT ARE OPEN TO AUDIT BY THE IRS AND STATE DEPARTMENTS OF REVENUE ARE GENERALLY THE TAX YEARS ENDED DECEMBER 31, 2012, THROUGH THE CURRENT TAX YEAR EXCEPT IN CERTAIN STATES WHERE THE OPEN TAX YEARS GENERALLY BEGIN WITH THE TAX YEAR ENDED DECEMBER 31, 2011. AS OF DECEMBER 31, 2015, THE COMPANY HAS NOT IDENTIFIED ANY UNCERTAIN TAX POSITIONS THAT WOULD REQUIRE THE RECORDING OF A TAX LIABILITY. THE COMPANY DOES NOT ANTICIPATE A CHANGE IN UNCERTAIN TAX POSITIONS FOR THE 12 MONTHS FOLLOWING THE YEAR ENDED DECEMBER 31, 2015. |
Schedule F IRS990ScheduleF
Account Activities Outside US AccountActivitiesOutsideUSGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Region | Central America and the Caribbean | RegionTxt |
| Type Of Activities Conducted | Program Services | TypeOfActivitiesConductedTxt |
| Specific Services Provided | CAPTIVE INSURANCE | SpecificServicesProvidedTxt |
| Region Total Expenditures | $534,761 | RegionTotalExpendituresAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Spent | $534,761 | SubtotalSpentAmt |
| Total Spent | $534,761 | TotalSpentAmt |
| Transfer To Foreign Corp | Yes (true) | TransferToForeignCorpInd |
| Interest In Foreign Trust | false | InterestInForeignTrustInd |
| Foreign Corp Ownership | Yes (true) | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | false | PassiveForeignInvestmestCoInd |
| Foreign Partnership | false | ForeignPartnershipInd |
| Boycott Countries | false | BoycottCountriesInd |
Schedule G IRS990ScheduleG
Fundraising Event Information FundraisingEventInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Event1 | GALA | Event1Nm |
| Gross Receipts Event1 | $80,094 | GrossReceiptsEvent1Amt |
| Charitable Contri Event1 | $74,017 | CharitableContriEvent1Amt |
| Gross Revenue Event1 | $6,077 | GrossRevenueEvent1Amt |
| Non Cash Prizes Event1 | $17,645 | NonCashPrizesEvent1Amt |
| Food And Beverage Event1 | $10,682 | FoodAndBeverageEvent1Amt |
| Entertainment Event1 | $25,000 | EntertainmentEvent1Amt |
| Other Direct Expenses Event1 | $15,978 | OtherDirectExpensesEvent1Amt |
| Event2 | LUNCHEON | Event2Nm |
| Gross Receipts Event2 | $36,219 | GrossReceiptsEvent2Amt |
| Charitable Contri Event2 | $24,459 | CharitableContriEvent2Amt |
| Gross Revenue Event2 | $11,760 | GrossRevenueEvent2Amt |
| Rent Facility Costs Event2 | $27,366 | RentFacilityCostsEvent2Amt |
| Food And Beverage Event2 | $7,000 | FoodAndBeverageEvent2Amt |
| Other Direct Expenses Event2 | $22,479 | OtherDirectExpensesEvent2Amt |
| Other Events Total | 2 | OtherEventsTotalCnt |
| Gross Receipts Other Events | $42,211 | GrossReceiptsOtherEventsAmt |
| Charitable Contri Other Events | $32,240 | CharitableContriOtherEventsAmt |
| Gross Revenue Other Events | $9,971 | GrossRevenueOtherEventsAmt |
| Non Cash Prizes Other Events | $2,345 | NonCashPrizesOtherEventsAmt |
| Rent Fclty Costs Other Events | $3,009 | RentFcltyCostsOtherEventsAmt |
| Food And Beverage Other Events | $3,009 | FoodAndBeverageOtherEventsAmt |
| Oth Direct Expnss Other Events | $9,672 | OthDirectExpnssOtherEventsAmt |
| Gross Receipts Total | $158,524 | GrossReceiptsTotalAmt |
| Charitable Contributions Tot | $130,716 | CharitableContributionsTotAmt |
| Gross Revenue Total Events | $27,808 | GrossRevenueTotalEventsAmt |
| Non Cash Prizes Total Events | $19,990 | NonCashPrizesTotalEventsAmt |
| Rent Fclty Costs Total Events | $30,375 | RentFcltyCostsTotalEventsAmt |
| Food And Beverage Total Events | $20,691 | FoodAndBeverageTotalEventsAmt |
| Entertainment Total Events | $25,000 | EntertainmentTotalEventsAmt |
| Oth Direct Expnss Total Events | $48,129 | OthDirectExpnssTotalEventsAmt |
| Direct Expense Summary Events | $144,185 | DirectExpenseSummaryEventsAmt |
| Net Income Summary | -$116,377 | NetIncomeSummaryAmt |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (true) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (4 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Purpose Of GrantPurposeOfGrantTxt |
|---|---|---|---|---|---|---|---|
| AMERICA'S BLOOD CENTERS | |||||||
| 725 15TH STR NW STE 700 | WASHINGTON | DC | 200052100 | 866052376 | 501(C)(6) | $27,500 | 2015 PLEDGE Support |
| AMERICAN ASSOCIATION OF BLOOD BANKS | |||||||
| 8101 GLENBROOK ROAD | BETHESDA | MD | 20814 | 362384118 | 501(C)(3) | $75,000 | CORD BLOOD PLEDGE |
| GLOBAL BLOOD FUND | |||||||
| 1001 N LINCOLN BLVD | OKLAHOMA CITY | OK | 73104 | 392071848 | 501(C)(3) | $10,000 | 2015 PLEDGE Support |
| FLIGHTS FOR LIFE | |||||||
| PO BOX 26485 | PHOENIX | AZ | 85068 | 742453899 | 501(C)(3) | $16,000 | General Support |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 3 | Total501c3OrgCnt |
| Total Other Org | 1 | TotalOtherOrgCnt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | SCHEDULE I, PART I, LINE 2 | FormAndLineReferenceDesc |
| Explanation | SPONSORSHIPS AND DONATIONS TO OTHER TAX-EXEMPT ENTITIES ARE MADE IN SUPPORT OF THEIR MISSIONS AND ARE MONITORED VIA THE GOVERNANCE PRACTICES OF THOSE ENTITIES. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Independent Consultant | Yes (X) | IndependentConsultantInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | Yes (true) | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | Yes (true) | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | false | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | false | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | false | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | false | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | false | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | Yes (true) | AnyNonFixedPaymentsInd |
| Initial Contract Exception | false | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (27 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| J Daniel Connor | ||||||||||||||
| President/CEO | $660,704 | $0 | $0 | $0 | $12,150 | $0 | $28,600 | $0 | $10,744 | $0 | $712,198 | $0 | $0 | $0 |
| Susan Barnes | ||||||||||||||
| Executive VP and CFO | $320,595 | $0 | $0 | $0 | $395,472 | $0 | $10,600 | $0 | $10,492 | $0 | $737,159 | $0 | $384,361 | $0 |
| David Green | ||||||||||||||
| Pres Blood Centers Division | $394,091 | $0 | $61,875 | $0 | $57,296 | $0 | $23,364 | $0 | $14,953 | $0 | $551,579 | $0 | $0 | $0 |
| Bhavi Shah | ||||||||||||||
| EVP/General Counsel | $216,214 | $0 | $15,000 | $0 | $11,112 | $0 | $10,113 | $0 | $14,312 | $0 | $266,751 | $0 | $0 | $0 |
| Mary Beth Bassett | ||||||||||||||
| EVP Chief Quality Officer | $298,959 | $0 | $125,000 | $0 | $12,064 | $0 | $28,600 | $0 | $6,918 | $0 | $471,541 | $0 | $952 | $0 |
| Michael Busch MD | ||||||||||||||
| SVP Research & Scientific Prog | $408,868 | $0 | $0 | $0 | $14,232 | $0 | $28,600 | $0 | $10,245 | $0 | $461,945 | $0 | $4,263 | $0 |
| Tom Choi | ||||||||||||||
| VP Inv Mngmt & Hosp Srvcs | $201,815 | $0 | $0 | $0 | $9,969 | $0 | $6,352 | $0 | $6,335 | $0 | $224,471 | $0 | $0 | $0 |
| Vicki Finson | ||||||||||||||
| VP Corporate Integration | $223,466 | $0 | $0 | $0 | $738 | $0 | $8,086 | $0 | $10,411 | $0 | $242,701 | $0 | $0 | $0 |
| Dennis Harpool | ||||||||||||||
| SVP Oper Policies & Processes | $219,476 | $0 | $0 | $0 | $9,969 | $0 | $3,716 | $0 | $17,059 | $0 | $250,220 | $0 | $0 | $0 |
| Robert Hartmann | ||||||||||||||
| VP Info Technology | $231,508 | $0 | $0 | $0 | $9,969 | $0 | $9,489 | $0 | $13,817 | $0 | $264,783 | $0 | $0 | $0 |
| Hany Kamel MD | ||||||||||||||
| VP Corporate Medical Director | $328,916 | $0 | $0 | $0 | $11,949 | $0 | $28,600 | $0 | $17,542 | $0 | $387,007 | $0 | $1,980 | $0 |
| Linda Matthews | ||||||||||||||
| President BioCARE | $300,364 | $0 | $170,464 | $0 | $14,644 | $0 | $28,600 | $0 | $16,363 | $0 | $530,435 | $0 | $3,532 | $0 |
| PETER MICHAELSON | ||||||||||||||
| VP HUMAN RESOURCES | $266,006 | $0 | $0 | $0 | $9,969 | $0 | $28,600 | $0 | $13,837 | $0 | $318,412 | $0 | $0 | $0 |
| Connie L Morris | ||||||||||||||
| VP Manufacturing & Lab Srvs | $170,563 | $0 | $0 | $0 | $9,969 | $0 | $6,849 | $0 | $13,631 | $0 | $201,012 | $0 | $0 | $0 |
| Phillip Norris | ||||||||||||||
| VP Research & Scientific Prog | $259,474 | $0 | $0 | $0 | $0 | $0 | $27,681 | $0 | $13,375 | $0 | $300,530 | $0 | $0 | $0 |
| Frank Nizzi MD | ||||||||||||||
| VP Clinical Services | $320,882 | $0 | $0 | $0 | $9,969 | $0 | $10,600 | $0 | $10,141 | $0 | $351,592 | $0 | $0 | $0 |
| Ralph Vassallo | ||||||||||||||
| EVP Chief Med & Scient Offcr | $341,680 | $0 | $15,000 | $0 | $112,452 | $0 | $7,950 | $0 | $5,883 | $0 | $482,965 | $0 | $0 | $0 |
| Paula Villalobos | ||||||||||||||
| VP Field Operations | $224,565 | $0 | $0 | $0 | $9,969 | $0 | $6,181 | $0 | $6,410 | $0 | $247,125 | $0 | $0 | $0 |
| Charles E Wilcox III | ||||||||||||||
| VP Ops/Blood Centers Division | $253,425 | $0 | $0 | $0 | $9,969 | $0 | $10,600 | $0 | $10,088 | $0 | $284,082 | $0 | $0 | $0 |
| Patrick Holt | ||||||||||||||
| EVP Business Services | $57,725 | $0 | $0 | $0 | $301,005 | $0 | $0 | $0 | $0 | $0 | $358,730 | $0 | $0 | $0 |
| Kevin Land MD | ||||||||||||||
| Sr Medical Director | $320,414 | $0 | $0 | $0 | $0 | $0 | $6,686 | $0 | $13,881 | $0 | $340,981 | $0 | $0 | $0 |
| Andrew Kirk | ||||||||||||||
| vp sales | $141,614 | $0 | $88,385 | $0 | $51,985 | $0 | $7,078 | $0 | $25,707 | $0 | $314,769 | $0 | $0 | $0 |
| pedro cano MD | ||||||||||||||
| sr medical DIR (thru 12/2015) | $265,984 | $0 | $0 | $0 | $11,449 | $0 | $7,950 | $0 | $967 | $0 | $286,350 | $0 | $0 | $0 |
| ROBIN CUSICK | ||||||||||||||
| CHIEF MEDICAL OFFICER | $272,590 | $0 | $0 | $0 | $0 | $0 | $28,500 | $0 | $2,161 | $0 | $303,251 | $0 | $0 | $0 |
| MARY TOWNSEND MD | ||||||||||||||
| SR MEDICAL DIRECTOR | $272,349 | $0 | $0 | $0 | $0 | $0 | $10,600 | $0 | $22,656 | $0 | $305,605 | $0 | $0 | $0 |
| SALLY CAGLIOTI | ||||||||||||||
| PRESIDENT CTS | $0 | $364,615 | $0 | $96,980 | $0 | $627,421 | $0 | $28,600 | $0 | $8,023 | $0 | $1,125,639 | $0 | $616,309 |
| EUGENE Robertson PHD | ||||||||||||||
| VICE PRESIDENT CTS | $0 | $122,561 | $0 | $68,220 | $0 | $4,431 | $0 | $25,689 | $0 | $8,517 | $0 | $229,418 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail (3 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| SCHEDULE J, PART I, LINE 4a | PATRICK HOLT received severance payments of $300,593 during 2015. This amount is taxable and is included in Schedule J, Part II, Column b(III). SCHEDULE J, PART I, LINE 4B CERTAIN EMPLOYEES RECEIVED DISTRIBUTIONS FROM THE SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN DURING 2015 AS FOLLOWS: SALLY CAGLIOTI: $616,309 (RESULTING FROM ALMOST 27 YEARS OF SERVICE) MARY BETH BASSETT: $952 (RESULTING FROM ALMOST 20 YEARS OF SERVICE) MICHAEL BUSCH, MD: $4,263 (RESULTING FROM ALMOST 17 YEARS OF SERVICE) HANY KAMEL, MD: $1,980 (RESULTING FROM ALMOST 20 YEARS OF SERVICE) LINDA MATTHEWS: $3,532 (RESULTING FROM ALMOST 16 YEARS OF SERVICE) SUSAN L. BARNES: $384,361 (RESULTING FROM ALMOST 26 YEARS OF SERVICE) THESE AMOUNTS WERE INCLUDED IN TAXABLE WAGES AND ARE REPORTED IN SCHEDULE J, PART II, COLUMN B(III) AND ALSO IN COLUMN F SINCE THESE AMOUNTS HAVE PREVIOUSLY BEEN REPORTED AS DEFERRED COMPENSATION ON A PRIOR FORM 990. THIS PLAN WAS FROZEN AS OF DECEMBER 31, 2011. |
| SCHEDULE J, PART I, LINE 7 | BLOOD SYSTEMS HAS AN INCENTIVE BONUS PLAN FOR MANAGEMENT AND EXECUTIVES. AWARDS UNDER THE PROGRAM ARE AT THE DISCRETION OF THE BOARD OF TRUSTEES. THE PLAN MEASURES PERFORMANCE AGAINST MULTIPLE METRICS WHICH CARRY VARIOUS WEIGHTINGS, THE MOST HEAVILY WEIGHTED BEING QUALITY, SAFETY AND CUSTOMER SERVICE. TO ASSURE FINANCIAL STABILITY OF THE COMPANY, ONE OF THE METRICS IS ALSO A MEASUREMENT OF NET MARGIN FINANCIAL PERFORMANCE AS A PERCENT OF REVENUES. |
| SCHEDULE J, PART II | David Green, Ralph Vassallo, Andrew Kirk and Pedro Cano received payments for relocation expenses. This amount is taxable and is included in Schedule J, Part II, Column B(III). DAVID GREEN, BHAVI SHAH, RALPH VASSALLO, AND ANDREW KIRK RECIEVED HIRING BONUSES, WHICH ARE INCLUDED IN SCHEDULE J, PART II, COLUMN B(II). MARY BETH BASSETT RECIEVED A RETRENTION BONUS, WHICH IS INCLUDED IN SCHEDULE J, PART II, COLUMN B(II). LINDA MATTHEWS IS THE PRESIDENT OF THE BIOCARE DIVISION OF BLOOD SYSTEMS. THIS DIVISION PERFORMED WELL ABOVE ITS BUDGETED EXPECTATION AND WAS GRANTED AN INCENTIVE BONUS UNDER THE COMPANY'S PLAN. |
Schedule K IRS990ScheduleK
Tax Exempt Bonds Issues TaxExemptBondsIssuesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Bond Reference | A | BondReferenceCd |
Issuer Name IssuerName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ARIZONA HEALTH FACILITIES AUTHORITY | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Bond Issuer EIN | 860453292 | BondIssuerEIN |
| Bond Issued | 2014-01-06 | BondIssuedDt |
| Issue Price | $27,005,000 | IssuePriceAmt |
| Purpose | SEE PART VI | PurposeDesc |
| Defeased | false | DefeasedInd |
| On Behalf Of Issuer | false | OnBehalfOfIssuerInd |
| Pool Financing | false | PoolFinancingInd |
Tax Exempt Bonds Proceeds TaxExemptBondsProceedsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Bond Reference | A | BondReferenceCd |
| Retired | $3,385,000 | RetiredAmt |
| Bond Defeased | $0 | BondDefeasedAmt |
| Total Proceeds | $27,005,000 | TotalProceedsAmt |
| In Reserve Fund | $0 | InReserveFundAmt |
| Capitalized Interest | $0 | CapitalizedInterestAmt |
| Refunding Escrow | $0 | RefundingEscrowAmt |
| Issuance Costs From Proceeds | $41,114 | IssuanceCostsFromProceedsAmt |
| Credit Enhancement | $0 | CreditEnhancementAmt |
| Working Capital Expenditures | $0 | WorkingCapitalExpendituresAmt |
| Capital Expenditures | $26,963,886 | CapitalExpendituresAmt |
| Other Spent Proceeds | $0 | OtherSpentProceedsAmt |
| Unspent | $0 | UnspentAmt |
| Substantial Completion | 2014 | SubstantialCompletionYr |
| Current Refunding | Yes (true) | CurrentRefundingInd |
| Advance Refunding | false | AdvanceRefundingInd |
| Final Allocation Made | Yes (true) | FinalAllocationMadeInd |
| Adequate Books And Rec Maint | Yes (true) | AdequateBooksAndRecMaintInd |
Tax Exempt Bonds Private Bus Use TaxExemptBondsPrivateBusUseGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Bond Reference | A | BondReferenceCd |
| Owning Bond Financed Property | false | OwningBondFinancedPropertyInd |
| Any Lease Arrangements | false | AnyLeaseArrangementsInd |
| Mgmt Contract Bond Fincd Prop | false | MgmtContractBondFincdPropInd |
| Any Research Agreements | Yes (true) | AnyResearchAgreementsInd |
| Engage Bond Counsel Research | false | EngageBondCounselResearchInd |
| Private Bus Use By Others | 0.00000 | PrivateBusUseByOthersPct |
| Private Bus Concerning UBI | 0.00700 | PrivateBusConcerningUBIPct |
| Total Private Business Use | 0.00700 | TotalPrivateBusinessUsePct |
| Bond Iss Meet Prvt Sec Pymt Test | false | BondIssMeetPrvtSecPymtTestInd |
| Change In Use Bond Financed Prop | false | ChangeInUseBondFinancedPropInd |
| Change In Use Bond Financed Prop | 0.00000 | ChangeInUseBondFinancedPropPct |
| Remedial Action Taken | false | RemedialActionTakenInd |
| Procs Nonqualified Bond Remdtd | Yes (true) | ProcsNonqualifiedBondRemdtdInd |
Tax Exempt Bonds Arbitrage TaxExemptBondsArbitrageGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Bond Reference | A | BondReferenceCd |
| Form8038 T Filed | false | Form8038TFiledInd |
| Exception To Rebate | Yes (true) | ExceptionToRebateInd |
| Variable Rate Issue | false | VariableRateIssueInd |
| Hedge Identified In Bks And Rec | false | HedgeIdentifiedInBksAndRecInd |
Hedge Provider Name HedgeProviderName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | 0 | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Proceeds Invested In GIC | false | GrossProceedsInvestedInGICInd |
GIC Provider Name GICProviderName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | 0 | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Proceeds Invested | false | GrossProceedsInvestedInd |
| Written Proc To Monitor Reqs | Yes (true) | WrittenProcToMonitorReqsInd |
Procedures Corrective Action ProceduresCorrectiveActionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Bond Reference | A | BondReferenceCd |
| Procedures Corrective Action | Yes (true) | ProceduresCorrectiveActionInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | . | FormAndLineReferenceDesc |
| Explanation | Schedule K, Part I, Line A, Column F REFUNDING OF AHFA 2004 BOND ISSUE WHICH WAS USED FOR THE PURCHASE OF LAND AND TO CONSTRUCT AND EQUIP 11 BLOOD CENTERS IN VARIOUS STATES FOR THE PURPOSE OF RECRUITING, COLLECTING, PROCESSING AND DISTRIBUTING BLOOD PRODUCTS; REFUNDING OF ABAG 2002 BOND ISSUE USED TO CONSTRUCT A BLOOD CENTER IN SAN FRANCISCO, CA; AND, REFUNDING OF AHFA 1995 VARIABLE RATE BOND ISSUE USED TO CONSTRUCT AND EQUIP A NATIONAL BLOOD TESTING LABORATORY IN TEMPE, ARIZONA. | ExplanationTxt |
Schedule L IRS990ScheduleL
Loans Btwn Org Interested Prsn LoansBtwnOrgInterestedPrsnGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | DAVID GREEN | PersonNm |
| Relationship With Org | OFFICER | RelationshipWithOrgTxt |
| Loan Purpose | HOUSE | LoanPurposeTxt |
| Loan From Organization | Yes (X) | LoanFromOrganizationInd |
| Original Principal | $150,000 | OriginalPrincipalAmt |
| Balance Due | $125,000 | BalanceDueAmt |
| Default | false | DefaultInd |
| Board Or Committee Approval | Yes (true) | BoardOrCommitteeApprovalInd |
| Written Agreement | Yes (true) | WrittenAgreementInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Balance Due | $125,000 | TotalBalanceDueAmt |
Bus Tr Involve Interested Prsn BusTrInvolveInterestedPrsnGrp
Name Of Interested NameOfInterested
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | orrin h camp | PersonNm |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Relationship Description | spouse of officer | RelationshipDescriptionTxt |
| Transaction | $89,686 | TransactionAmt |
| Transaction | COMPENSATION - BSI EMPLOYEE | TransactionDesc |
| Sharing Of Revenues | false | SharingOfRevenuesInd |
Schedule M IRS990ScheduleM
| Field | Value | IRS element (for citing) |
|---|---|---|
| Works Of Art | WorksOfArtGrp | |
| Art Historical Treasures | ArtHistoricalTreasuresGrp | |
| Art Fractional Interest | ArtFractionalInterestGrp | |
| Books And Publications | BooksAndPublicationsGrp | |
| Clothing And Household Goods | ClothingAndHouseholdGoodsGrp | |
| Cars And Other Vehicles | CarsAndOtherVehiclesGrp | |
| Boats And Planes | BoatsAndPlanesGrp | |
| Intellectual Property | IntellectualPropertyGrp | |
| Securities Publicly Traded | SecuritiesPubliclyTradedGrp | |
| Securities Closely Held Stock | SecuritiesCloselyHeldStockGrp | |
| Secur Prtnrshp Trust Intrsts | SecurPrtnrshpTrustIntrstsGrp | |
| Securities Miscellaneous | SecuritiesMiscellaneousGrp | |
| Qualified Contrib Hist Struct | QualifiedContribHistStructGrp | |
| Qualified Contrib Other | QualifiedContribOtherGrp | |
| Real Estate Residential | RealEstateResidentialGrp | |
| Real Estate Commercial | RealEstateCommercialGrp | |
| Real Estate Other | RealEstateOtherGrp | |
| Collectibles | CollectiblesGrp | |
| Food Inventory | FoodInventoryGrp | |
| Drugs And Medical Supplies | DrugsAndMedicalSuppliesGrp | |
| Taxidermy | TaxidermyGrp | |
| Historical Artifacts | HistoricalArtifactsGrp | |
| Scientific Specimens | ScientificSpecimensGrp | |
| Archaeological Artifacts | ArchaeologicalArtifactsGrp |
Other Non Cash Contri Table OtherNonCashContriTableGrp (3 entries)
| Non Cash CheckboxNonCashCheckboxInd | DescDesc | ContributionContributionCnt | Noncash Contributions Rpt F990NoncashContributionsRptF990Amt | Method Of Determining RevenuesMethodOfDeterminingRevenuesTxt |
|---|---|---|---|---|
| Yes (X) | RECOGNITION | 352 | $5,275,493 | COST/SELLING PRICE |
| Yes (X) | REFRESHMENT | 63 | $18,313 | COST/SELLING PRICE |
| Yes (X) | OTHER | 4 | $423 | COST/SELLING PRICE |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form8283 Received | 0 | Form8283ReceivedCnt |
| Any Property That Must Be Held | false | AnyPropertyThatMustBeHeldInd |
| Review Process Unusual NC Gifts | Yes (true) | ReviewProcessUnusualNCGiftsInd |
| Third Parties Used | false | ThirdPartiesUsedInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | SCHEDULE M, PART I, COLUMN (B) | FormAndLineReferenceDesc |
| Explanation | THE ORGANIZATION IS REPORTING THE NUMBER OF CONTRIBUTIONS RECEIVED IN COLUMN (B). | ExplanationTxt |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (10 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, PART III, LINE 1 | THE MISSION OF BLOOD SYSTEMS, INC. ("BSI") IS TO MAKE A DIFFERENCE IN PEOPLE'S LIVES BY BRINGING TOGETHER THE BEST PEOPLE, INSPIRING INDIVIDUALS TO DONATE BLOOD, PRODUCING A SAFE AND AMPLE BLOOD SUPPLY, ADVANCING CUTTING-EDGE RESEARCH AND EMBRACING CONTINUOUS QUALITY IMPROVEMENT. TO FURTHER ITS MISSION, BSI OPERATES 17 COMMUNITY BLOOD CENTERS. THESE CENTERS RECRUIT BLOOD DONORS AND COLLECT, PROCESS AND DISTRIBUTE APPROXIMATELY 860,000 BLOOD DONATIONS TO MEET THE BLOOD NEEDS OF PATIENTS IN MORE THAN 500 HOSPITALS THROUGHOUT THE COUNTRY. THE STAFF OF NEARLY 2,300 SERVES A GEOGRAPHIC AREA COVERING THE UNITED STATES, FROM THE EAST COAST TO CALIFORNIA AND FROM THE CANADIAN BORDER TO MEXICO. BSI IS KNOWN MORE COMMONLY THROUGHOUT THE UNITED STATES BY THE NAME OF ITS BLOOD BANKING DIVISION, UNITED BLOOD SERVICES. BSI IS LICENSED BY THE U.S. FOOD AND DRUG ADMINISTRATION ("FDA") AS A PROVIDER OF BLOOD AND BLOOD SERVICES. THE COMPANY'S THREE OPERATING DIVISIONS ARE: (1) THE BLOOD BANKING DIVISION, WHICH INCLUDES UNITED BLOOD SERVICES; (2) THE BIOCARE DIVISION; AND (3) THE BLOOD SYSTEMS RESEARCH INSTITUTE. THESE OPERATING DIVISIONS ARE UNINCORPORATED DIVISIONS DOING BUSINESS UNDER REGISTERED TRADENAMES AND SERVICE MARKS. BSI CONDUCTS ITS BLOOD BANKING ACTIVITIES THROUGH ITS REGIONAL BLOOD CENTERS LOCATED IN THE FOLLOWING STATES: ARIZONA, CALIFORNIA, COLORADO, LOUISIANA, MISSISSIPPI, MONTANA, NEVADA, NEW MEXICO, NORTH DAKOTA, SOUTH DAKOTA, TEXAS, OHIO, NEW JERSEY, AND WYOMING. THE BIOCARE DIVISION DISTRIBUTES PLASMA-DERIVED PRODUCTS THROUGH HOSPITALS, COMMUNITY BLOOD CENTER LOCATIONS AND ALSO DIRECTLY FROM ITS HEADQUARTERS IN TEMPE, ARIZONA. BLOOD-RELATED RESEARCH IS CONDUCTED AT THE BLOOD SYSTEMS RESEARCH INSTITUTE LOCATED IN SAN FRANCISCO, CALIFORNIA. FORM 990, PART III, LINE 2 ON JANUARY 1, 2015 BSI EFFECTED A MEMBER SUBSTITUTION (ACQUIRED) WITH LIFESHARE COMMUNITY BLOOD SERVICES, INC ("lIFESHARE"). LIFESHARE IS A COMMUNITY-FOCUSED NONPROFIT ORGANIZATION COMMITTED TO PROVIDING A SAFE AND ADEQUATE BLOOD SUPPLY AND COMPONENT SUPPLY FOR PATIENT HEALTHCARE IN NORTHEAST OHIO. ON FEBRUARY 1, 2015 BSI EFFECTED A MEMBER SUBSTITUTION (ACQUIRED) WITH BERGEN COMMUNITY REGIONAL BLOOD CENTER, INC ("cOMMUNITY BLOOD SERVICES"). COMMUNITY BLOOD SERVICES PROMOTeS THE HEALTH OF THE COMMUNITY BY PROVIDING HIGH-QUALITY BLOOD AND TISSUE SERVICES. ON NOVEMBER 1, 2015 BSI EFFECTED A MEMBER SUBSTITUTION (ACQUIRED) WITH MID-SOUTH REGIONAL BLOOD CENTER, INC ("MID-SOUTH"). MID-SOUTH IS A COMMUNITY-FOCUSED NONPROFIT ORGANIZATION COMMITTED TO PROVIDING A SAFE AND ADEQUATE BLOOD SUPPLY FOR PATIENT HEALTHCARE IN THE MID-SOUTH REGION. |
| FORM 990, PART III, LINES 4A-D | 4A) UNITED BLOOD SERVICES - BLOOD BANKING THE BLOOD BANKING DIVISION OPERATES UNDER THE NAME UNITED BLOOD SERVICES ("UBS"). THE PRIMARY PURPOSE OF UBS IS TO PROVIDE A SAFE AND STABLE SUPPLY OF BLOOD AND BLOOD COMPONENTS TO HOSPITALS AND MEDICAL FACILITIES. THE STRENGTH OF UBS IS THAT IT OPERATES AS LOCAL BLOOD CENTERS THAT ARE PART OF THE COMMUNITY AND YET HAS ACCESS TO A LARGE NETWORKED ORGANIZATION WITH ALL THE ADVANTAGES AND EFFICIENCIES THAT ARE REALIZED THROUGH STANDARDIZATION AND ECONOMIES OF SCALE. UBS COLLECTS BLOOD FROM VOLUNTEER DONORS, PERFORMS SCREENING AND TESTING ON THE DONATED BLOOD, AND PROCESSES THE WHOLE BLOOD INTO BLOOD COMPONENTS SUCH AS RED CELLS, PLATELETS AND PLASMA. BLOOD AND BLOOD COMPONENTS ARE THEN STORED AND DISTRIBUTED TO HOSPITALS AND OTHER HEALTH CARE PROVIDERS. 4B) BIOCARE - BIOLOGICALS THE BIOCARE DIVISION PROVIDES BIOLOGICAL PRODUCTS, BOTH HUMAN-PLASMA DERIVED AND RECOMBINANT PRODUCTS, THAT SERVE AS ADJUNCT THERAPIES IN TRANSFUSION MEDICINE AND HEALTHCARE. PLASMA DERIVATIVES ARE BASICALLY PROTEIN THERAPIES PROVIDED FROM PLASMA LEFT OVER FROM WHOLE BLOOD DONATIONS. EXAMPLES OF SUCH PLASMA DERIVATIVES INCLUDE: INTRAVENOUS IMMUNE GLOBULINS, COAGULATION FACTORS, ALBUMIN AND FIBRIN SEALANTS. THESE PRODUCTS ARE USED AS THERAPIES FOR IMMUNE SYSTEM DISORDERS, BLEEDING DISORDERS AND WOUND MANAGEMENT. RECOMBINANT-BASED PRODUCTS ARE PRODUCTS THAT ARE NOT MADE FROM FRACTIONATED HUMAN PLASMA. INSTEAD, THESE PRODUCTS ARE GENETICALLY ENGINEERED. THE RESULTING PRODUCT HAS THE STRUCTURAL AND FUNCTIONAL CHARACTERISTICS SIMILAR TO THE COMPONENT FOUND IN HUMAN PLASMA (OR BASED ON A PROTEIN IN HUMAN PLASMA) THAT THE DRUG WAS SYNTHESIZED TO IMITATE. RECOMBINANT-BASED PRODUCTS ARE OFTEN STABILIZED WITH ALBUMIN (CONCENTRATE OF PLASMA PROTEINS FROM HUMAN PLASMA), BUT THESE PRODUCTS ARE NOT MANUFACTURED FROM HUMAN PLASMA. THESE RECOMBINANT PRODUCTS, SIMILAR TO THE PLASMA-DERIVATIVE PRODUCTS, ARE USED TO TREAT DISEASES AND MEDICAL CONDITIONS THAT ARE CONNECTED WITH OR RELATED TO BLOOD OR BLOOD-BORNE MEDICAL CONDITIONS. 4C) BLOOD SYSTEMS RESEARCH INSTITUTE BLOOD SYSTEMS RESEARCH INSTITUTE ("BSRI") FACILITATES RESEARCH PRIMARILY FUNDED BY EXTRAMURAL GRANTS (NIH AND OTHERS). THE RESEARCH IS IN TRANSFUSION MEDICINE EPIDEMIOLOGY, HEALTH POLICY, VIROLOGY, VIRAL DISCOVERY, THE IMMUNE REACTION TO TRANSFUSION AND TO TRANSFUSION-TRANSMITTED INFECTIOUS AGENTS, CELL THERAPY AND GENETIC EPIDEMIOLOGY. AREAS STUDIED INCLUDE IMPLICATIONS OF RECEIVING COMPONENTS AT DIFFERENT STORAGE AGES; MECHANISM OF VIRUS ENTRY INTO CELLS; HOW TRANSFUSION TRANSMITTED VIRUSES CAUSE SYMPTOMS; THE USE OF COMMERCIALLY AVAILABLE OR LOCALLY-DEVELOPED DONOR TESTS; THE FACTORS LEADING TO CHIMERISM, ETC. BSRI SUPPORTS TRAINING PROGRAMS FOR SPECIALISTS IN TRANSFUSION MEDICINE AND THE DEVELOPMENT OF EPIDEMIOLOGY RESEARCH SCIENTISTS. BSRI INVESTIGATORS PUBLISH MORE THAN 45 PAPERS EACH YEAR IN THE PEER-REVIEWED SCIENTIFIC LITERATURE. THE RESEARCH FACILITY IS STAFFED WITH 12 INVESTIGATORS, 24 RESEARCH ASSOCIATES, 16 STAFF SCIENTISTS AND VARIOUS OTHER POSITIONS AS WELL AS ADMINISTRATIVE SUPPORT. 4D) OTHER PROGRAM SERVICES CONSIST OF LABORATORY SERVICES AND OTHER PROGRAM ACTIVITIES. |
| FORM 990, PART VI, LINE 1A | THE EXECUTIVE COMMITTEE HAS THE POWERS OF THE BOARD OF TRUSTEES BETWEEN BOARD MEETINGS, UNLESS PROHIBITED BY LAW OR THE ARTICLES OF INCORPORATION. THE EXECUTIVE COMMITTEE IS COMPOSED OF 6 OR MORE TRUSTEES, INCLUDING THE CHAIR, VICE CHAIR, SECRETARY-TREASURER, ONE TRUSTEE SELECTED BY BLOOD CENTERS OF THE PACIFIC, AND TWO OR MORE TRUSTEES SELECTED BY THE BOARD. |
| FORM 990, PART VI, LINE 11B | THE FORM 990 IS REVIEWED BY MANAGEMENT, INCLUDING CONFIRMATION OF COMPENSATION DISCLOSURES AGAINST W-2 AND 1099 REPORTING. A COPY OF THE DRAFT FORM 990 AND ALL SCHEDULES IS SUPPLIED TO ALL BOARD MEMBERS PRIOR TO THE MEETING HELD TO ACCEPT THE RETURNS. THE W-2S AND 1099S ARE AVAILABLE FOR BOARD REVIEW UPON REQUEST. THE PAID PREPARER, ERNST & YOUNG, AND MEMBERS OF MANAGEMENT REVIEW THE FORM 990 WITH THE COMMITTEES AND ARE AVAILABLE FOR ANSWERING QUESTIONS. ANY COMMENTS FROM THE BOARD ARE CONSIDERED PRIOR TO FILING WITH THE IRS. |
| FORM 990, PART VI, LINE 12C | EACH YEAR, THE BOARD OF TRUSTEES AND SENIOR MANAGEMENT ARE REQUIRED TO SIGN AND RETURN A CONFLICT OF INTEREST FORM TO COMPANY COUNSEL. ANY CONFLICTS DISCLOSED ARE DISCUSSED IN EXECUTIVE SESSION WITH THE BOARD AND RESOLVED. IN ADDITION, IN PREPARATION FOR THE FORM 990 FILING, THE TRUSTEES, OFFICERS AND KEY EMPLOYEES IDENTIFIED ARE REQUIRED TO RESPOND TO A COMPREHENSIVE CONFLICT OF INTEREST AND FAMILY RELATIONSHIP QUESTIONNAIRE. ANY CONFLICTS DISCLOSED ARE DISCUSSED WITH THE BOARD AND DISCLOSED APPROPRIATELY ON THE FORM 990. |
| FORM 990, PART VI, LINES 15A AND 15B | THE BOARD OF TRUSTEES HAS A COMPENSATION AND HUMAN RESOURCE COMMITTEE WHOSE PURPOSE, AMONG OTHER THINGS, IS TO HIRE AN INDEPENDENT CONSULTING FIRM ONCE EVERY 2-3 YEARS TO PROVIDE DATA ON COMPETITIVENESS OF SALARIES AND BENEFITS FOR THE CEO AND OTHER OFFICERS OF THE CORPORATION. THE MEMBERS OF THE HUMAN RESOURCE AND COMPENSATION COMMITTEE OF THE BOARD ARE ALL INDEPENDENT TRUSTEES AND INCLUDE NO MEMBERS OF MANAGEMENT. THE RECOMMENDATIONS OF THE COMMITTEE ARE REVIEWED BY THE ENTIRE BOARD PRIOR TO APPROVAL. COMPENSATION FOR THESE INDIVIDUALS IS SET AND APPROVED BY THE BOARD EACH YEAR. THE RESULTS OF THESE DISCUSSIONS, REVIEWS AND APPROVALS ARE DOCUMENTED IN THE EXECUTIVE MINUTES OF THE BOARD MEETINGS. THIS PROCESS WAS LAST COMPLETED IN 2015. |
| FORM 990, PART VI, LINE 19 | THE FORM 990 IS MADE AVAILABLE ON THE COMPANY'S INTRA-NET FOR ALL OPERATING LOCATIONS TO ACCESS. UPON REQUEST, THE FORM CAN BE PRINTED OR VIEWED ON-LINE. UPON WRITTEN REQUEST TO THE CHIEF FINANCIAL OFFICER, A COPY OF THE FORM 990 WILL BE MAILED TO THE REQUESTOR. THE FORM 990 FOR CURRENT AND PAST YEARS IS ALSO POSTED ON GUIDESTAR FOR ORGANIZATIONS TO ACCESS. THE GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE NOT MADE AVAILABLE TO THE PUBLIC. THE ORGANIZATION'S COMBINED FINANCIAL STATEMENTS ARE MADE PUBLIC VIA THE ANNUAL REPORT POSTED ON THE ORGANIZATION'S WEBSITE. |
| FORM 990, PART VII | IN 2012, SALLY CAGLIOTI AND EUGENE ROBERTSON WERE REPORTED AS AN OFFICER AND KEY EMPLOYEE, RESPECTIVELY, OF BLOOD SYSTEMS, INC. ("BSI"). CREATIVE TESTING SOLUTIONS ("CTS"), A RELATED 501(C)(3) ORGANIZATION, LEASED THEIR EMPLOYEES FROM BSI IN 2012, INCLUDING SALLY CAGLIOTI AND EUGENE ROBERTSON. IN 2013 CTS HIRED THEIR OWN EMPLOYEES, INCLUDING SALLY CAGLIOTI AND EUGENE ROBERTSON. THUS, THEY ARE NO LONGER CONSIDERED AN OFFICER OR KEY EMPLOYEE OF BSI. FOR THIS REASON, THEY ARE BEING REPORTED AS FORMER. |
| FORM 990, PART VIII, LINE 2A | AS DESCRIBED IN THE NARRATIVE FOR PART III, LINE 4B, BIOCARE IS A DIVISION OF BLOOD SYSTEMS INC. THE BIOCARE DIVISION WAS CONCEIVED TO PROVIDE BLOOD BANK REAGENTS AND TRANSFUSION MEDICINE-RELATED, PLASMA-DERIVED PHARMACEUTICAL DERIVATIVES TO EXISTING HOSPITAL CUSTOMERS AS A CONVENIENT, VALUE-ADDED SERVICE. CURRENTLY, BIOCARE FUNCTIONS AS A SPECIALTY DISTRIBUTOR OF THERAPEUTIC PLASMA-DERIVATIVE PRODUCTS AND, INCREASINGLY, RECOMBINANT-BASED PRODUCTS TO BLOOD SYSTEMS TRADITIONAL CUSTOMER BASE OF HOSPITALS, AS WELL AS OUT-PATIENT SURGERY CENTERS, SPECIALTY PHARMACIES AND PHYSICIAN PRACTICES. THE MAJORITY OF PRODUCTS SOLD ARE USED TO TREAT DISEASES AND MEDICAL CONDITIONS THAT ARE CONNECTED WITH OR RELATED TO BLOOD OR BLOOD-BORNE MEDICAL CONDITIONS. ALL OF THE PRODUCTS SOLD BY BIOCARE ARE MANUFACTURED BY COMMERCIAL BIO-PHARMACEUTICAL COMPANIES. THE SIGNIFICANT DIFFERENCE BETWEEN BIOCARE AND ITS FOR-PROFIT COMPETITORS IN TERMS OF PRICING IS THAT IN THE EVENT THERE IS A SHORTAGE OF CERTAIN PRODUCT, THE FOR-PROFIT COMPETITORS MAY RAISE THEIR PRICING UP TO TWO OR THREE TIMES NORMAL PRICING, WHILE BIOCARE MAINTAINS ITS PRICING VERY CLOSE TO ORIGINAL LEVELS, ONLY INCREASING PRICING TO OFFSET INCREASED ACQUISITION COSTS. THE REASON BIOCARE HAS TAKEN THIS APPROACH IS DUE TO BSIS EXEMPT PURPOSE TO DELIVER PRODUCTS FOR TRANSFUSION AND TREATMENT PURPOSES. BIOCARE ALSO DIFFERS FROM ITS FOR-PROFIT COMPETITORS IN THAT BIOCARES DISTRIBUTION SERVICES OFFER SAME-DAY AND STAT DELIVERY OPTIONS OVER THE WEEKEND OR AFTER HOURS FOR A MUCH LOWER COST THAN ITS FOR-PROFIT COMPETITORS. BIOCARE REPRESENTS THE FASTEST POSSIBLE OPTION OF GETTING LIFE-SAVING PLASMA-DERIVED AND RECOMBINANT-BASED PRODUCTS TO ITS TRADITIONAL CUSTOMER BASE OVER THE WEEKEND (FRIDAY, SATURDAY AND SUNDAY). MOST FOR-PROFIT COMPETITORS DO PROVIDE 24 HOUR ORDERING SERVICES; HOWEVER, UNLESS AN ORDER IS RECEIVED PRIOR TO THE CLOSE OF BUSINESS ON THURSDAY, THE PRODUCT WILL NOT BE DELIVERED UNTIL THE FOLLOWING WEEK. BIOCARE ALSO USES APPROXIMATELY 20 ORDERING LOCATIONS (FACILITIES) NATIONWIDE THAT ARE CAPABLE OF STORING AND DISTRIBUTING PRODUCT, WHILE MOST COMPETITORS ONLY HAVE A FEW. IT SHOULD BE NOTED THAT THE ACTIVITIES UNDERTAKEN BY BLOOD SYSTEMS RELATED TO ITS EXEMPT PURPOSES AS A WHOLE ARE SUBSTANTIAL AS COMPARED TO THE ACTIVITIES OF THE BIOCARE DIVISION. WHILE BIOCARE COMPRISES A SIGNIFICANT PORTION OF BSIS OVERALL REVENUE, THE NUMBER OF EMPLOYEES (APPROXIMATELY 43) AND HOURS PRODUCING THIS REVENUE IS VERY SMALL, AS COMPARED TO THE TOTAL NUMBER OF BSI EMPLOYEES (APPROXMATELY 2,800) AND HOURS PRODUCING THE RELATED EXEMPT PURPOSE REVENUE. PLASMA-DERIVATIVE PRODUCTS TREATED AS RELATED (COL B) - PLASMA-DERIVATIVE PRODUCTS ARE PRODUCTS THAT ARE MANUFACTURED FROM PROTEINS FOUND IN HUMAN PLASMA AND ARE USED TO TREAT DISEASES AND MEDICAL CONDITIONS THAT ARE CONNECTED WITH OR RELATED TO BLOOD OR BLOOD BORNE MEDICAL CONDITIONS. IT IS BLOOD SYSTEMS POSITION THAT PROVIDING BLOOD-DERIVED PRODUCTS, WHICH ARE MANUFACTURED BY BIO-PHARMACEUTICAL COMPANIES USING HUMAN BLOOD/PLASMA, TO HOSPITALS AND OTHER HEALTHCARE PROVIDERS FOR USE IN TREATING MEDICAL CONDITIONS OF PATIENTS IS DIRECTLY RELATED TO BLOOD SYSTEMS EXEMPT PURPOSES. AS THE PRODUCTS SOLD ARE MADE FROM AND CONTAIN HUMAN BLOOD/PLASMA AND PROTEIN, THERE IS A SUBSTANTIAL NEXUS BETWEEN THE SALE OF THESE PRODUCTS AND BLOOD SYSTEMS EXEMPT PURPOSES. IT SHOULD BE NOTED THAT OTHER NON-PROFIT COMPETITORS ALSO TREAT SIMILAR REVENUE AS RELATED, THUS MAKING IT AN INDUSTRY STANDARD. ACCORDINGLY, THE SALE OF PLASMA-DERIVATIVE PRODUCTS IS BEING TREATED AS RELATED REVENUE (SEE PART VIII, LINE 2A, COLUMN (B)). RECOMBINANT-BASED PRODUCTS TREATED AS UNRELATED (COL C) - RECOMBINANT-BASED PRODUCTS ARE PRODUCTS THAT ARE NOT MADE FROM FRACTIONATED HUMAN PLASMA. INSTEAD, THESE PRODUCTS ARE GENETICALLY ENGINEERED. THE RESULTING PRODUCT HAS THE STRUCTURAL AND FUNCTIONAL CHARACTERISTICS SIMILAR TO THE COMPONENT FOUND IN HUMAN PLASMA (OR BASED ON A PROTEIN IN HUMAN PLASMA) THAT THE DRUG WAS SYNTHESIZED TO IMITATE. IT IS BSIS POSITION THAT THE PROVISION OF RECOMBINANT-BASED DRUG PRODUCTS, WHICH ARE MANUFACTURED THROUGH GENETIC ENGINEERING BY BIO-PHARMACEUTICAL COMPANIES NOT USING HUMAN BLOOD/PLASMA, TO HOSPITALS AND OTHER HEALTHCARE PROVIDERS USED TO TREAT MEDICAL CONDITIONS IS NOT DIRECTLY RELATED TO BLOOD SYSTEMS PURPOSES. ACCORDINGLY, THE SALE OF RECOMBINANT-BASED PRODUCTS IS BEING TREATED AS UNRELATED BUSINESS INCOME (SEE PART VIII, LINE 2A, COLUMN (C)). DUE TO THE GROWTH IN AND EXPANSION OF THE BIOCARE DIVISION, AND THE POSITION RECENTLY TAKEN TO TREAT RECOMBINANT PRODUCTS AS UNRELATED BUSINESS INCOME, BLOOD SYSTEMS INC. FORMED BIOCARE, INC., AN ARIZONA FOR-PROFIT C CORPORATION EFFECTIVE SEPTEMBER 15, 2016. IT IS INTENDED THAT THE BIOCARE DIVISION OF BLOOD SYSTEMS, INC., IN ITS ENTIRETY, WILL BE TRANSFERRED TO AND OPERATED BY BIOCARE, INC. EFFECTIVE JANUARY 1, 2017. |
| FORM 990, PART XI, LINE 9 | CTS DISTRIBUTION OF EARNINGS $ 6,500,000 CSIC DISTRIBUTION OF EARNINGS $ 5,000,000 PENSION RECAPTURE EXP OTHER THAN NET PERIODIC COST $(3,294,514) ----------- TOTAL $ 8,205,486 |
Schedule R IRS990ScheduleR
Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (9 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | EINEIN | Primary ActivitiesPrimaryActivitiesTxt | Legal Domicile StateLegalDomicileStateCd | Exempt Code SectionExemptCodeSectionTxt | Public Charity StatusPublicCharityStatusTxt | Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt | Controlled OrganizationControlledOrganizationInd |
|---|---|---|---|---|---|---|---|---|---|---|
| CREATIVE TESTING SOLUTIONS | ||||||||||
| 6210 EAST OAK STREET | SCOTTDALE | AZ | 85257 | 271120123 | SAFETY TEST. | AZ | 501(C)(3) | 10 | BSI | Yes (true) |
| BLOOD CENTERS OF THE PACIFIC | ||||||||||
| 270 MASONIC AVENUE | SAN FRANCISCO | CA | 94118 | 941156555 | BLOOD BANKING | CA | 501(C)(3) | 9 | BSI | Yes (true) |
| INLAND NORTHWEST BLOOD CENTER | ||||||||||
| 210 W CATALDO AVENUE | SPOKANE | WA | 99201 | 910499130 | BLOOD BANKING | WA | 501(C)(3) | 9 | BSI | Yes (true) |
| BLOOD CENTER FND OF THE INLAND NORTHWEST | ||||||||||
| 210 W CATALDO AVENUE | SPOKANE | WA | 99201 | 464347438 | FUNDRAISING | WA | 501(C)(3) | 7 | INBC | Yes (true) |
| BELLE BONFILS MEMORIAL BLOOD CENTER | ||||||||||
| 717 YOSEMITE STREET | DENVER | CO | 80230 | 840411209 | BLOOD BANKING | CO | 501(C)(3) | 9 | BSI | Yes (true) |
| BONFILS BLOOD CENTER FOUNDATION | ||||||||||
| 717 YOSEMITE STREET | DENVER | CO | 80230 | 742787586 | FUNDRAISING | CO | 501(C)(3) | 7 | BBMBC | Yes (true) |
| BLOOD BANK OF SAN BERNARDINO & RIVERSIDE | ||||||||||
| PO BOX 1429 | SAN BERNARDINO | CA | 92402 | 951708743 | BLOOD BANKING | CA | 501(C)(3) | 9 | BSI | Yes (true) |
| BLOOD BANK SAN BERNARDINORIVERSIDE FDN | ||||||||||
| PO BOX 1429 | SAN BERNARDINO | CA | 92402 | 208911074 | FUNDRAISING | CA | 501(C)(3) | 11-TYPE I | BBSBRC | Yes (true) |
| MID-SOUTH REGIONAL BLOOD CENTER INC | ||||||||||
| 1040 MADISON AVENUE | MEMPHIS | TN | 38104 | 620719021 | BLOOD BANKING | TN | 501(C)(3) | 9 | BSI | Yes (true) |
Id Related Org Txbl Partnership IdRelatedOrgTxblPartnershipGrp
Related Organization Name RelatedOrganizationName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | IT SYNERGISTICS LLC | BusinessNameLine1Txt |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 115 TREE ST | AddressLine1Txt |
| City | FLOWOOD | CityNm |
| State Abbreviation | MS | StateAbbreviationCd |
| ZIP | 39232 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 202570319 | EIN |
| Primary Activities | SOFTWARE DEV. | PrimaryActivitiesTxt |
| Legal Domicile State | MS | LegalDomicileStateCd |
Direct Controlling Entity Name DirectControllingEntityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | LS & BCRBC | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Predominant Income Type | RELATED | PredominantIncomeTypeTxt |
| Share Of Total Income | $0 | ShareOfTotalIncomeAmt |
| Share Of EOY Assets | $0 | ShareOfEOYAssetsAmt |
| Disproportionate Allocations | false | DisproportionateAllocationsInd |
| UBI Code V | $0 | UBICodeVAmt |
| General Or Managing Partner | false | GeneralOrManagingPartnerInd |
| Ownership | 0.00000 | OwnershipPct |
Id Related Org Txbl Corp Tr IdRelatedOrgTxblCorpTrGrp (2 entries)
| Address Line1ForeignAddress/AddressLine1Txt | CityForeignAddress/CityNm | CountryForeignAddress/CountryCd | EINEIN | Primary ActivitiesPrimaryActivitiesTxt | Legal Domicile Foreign CountryLegalDomicileForeignCountryCd | Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt | Entity TypeEntityTypeTxt | Share Of Total IncomeShareOfTotalIncomeAmt | Share Of EOY AssetsShareOfEOYAssetsAmt | OwnershipOwnershipPct | Controlled OrganizationControlledOrganizationInd | Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Legal Domicile StateLegalDomicileStateCd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CANYON STATE INSURANCE COMPANY | ||||||||||||||||
| WEST BAY ROAD | GRAND CAYMAN | CJ | 981084327 | INVESTMENT | CJ | BSI | FOREIGN | $9,045,046 | $27,629,825 | 1.00000 | Yes (true) | |||||
| TRANSFUSION TECHNOLOGY INC | ||||||||||||||||
| 223494865 | INACTIVE | BCRBC | C CORP | $0 | $0 | 0.00000 | Yes (true) | 102 CHESTNUT RIDGE ROAD | MONTVALE | NJ | 07645 | NJ | ||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | Yes (true) | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | false | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | Yes (true) | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | false | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | false | LoansOrGuaranteesFromOthOrgInd |
| Div Related Organization | Yes (true) | DivRelatedOrganizationInd |
| Asset Sale To Other Org | Yes (true) | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | Yes (true) | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | false | AssetExchangeInd |
| Rental Of Facilities To Oth Org | Yes (true) | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | Yes (true) | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | Yes (true) | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | Yes (true) | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | false | SharingOfFacilitiesInd |
| Paid Employees Sharing | false | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | Yes (true) | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | Yes (true) | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | Yes (true) | TransferToOtherOrgInd |
| Transfer From Other Org | Yes (true) | TransferFromOtherOrgInd |
Transactions Related Org TransactionsRelatedOrgGrp (42 entries)
| Transaction TypeTransactionTypeTxt | InvolvedInvolvedAmt | Method Of Amount DeterminationMethodOfAmountDeterminationTxt |
|---|---|---|
| BLOOD CENTERS OF THE PACIFIC | ||
| C | $399,326 | ACCRUAL |
| BLOOD CENTERS OF THE PACIFIC | ||
| G | $3,488,226 | ACCRUAL |
| BLOOD CENTERS OF THE PACIFIC | ||
| H | $126,615 | ACCRUAL |
| BLOOD CENTERS OF THE PACIFIC | ||
| K | $1,616,582 | ACCRUAL |
| BLOOD CENTERS OF THE PACIFIC | ||
| L | $3,103,464 | ACCRUAL |
| BLOOD CENTERS OF THE PACIFIC | ||
| M | $186,289 | ACCRUAL |
| BLOOD CENTERS OF THE PACIFIC | ||
| Q | $296,849 | ACCRUAL |
| BLOOD CENTERS OF THE PACIFIC | ||
| S | $293,813 | ACCRUAL |
| CANYON STATE INSURANCE COMPANY | ||
| F | $5,000,000 | ACCRUAL |
| CANYON STATE INSURANCE COMPANY | ||
| R | $534,761 | ACCRUAL |
| CREATIVE TESTING SOLUTIONS | ||
| M | $30,993,748 | ACCRUAL |
| CREATIVE TESTING SOLUTIONS | ||
| L | $5,981,821 | ACCRUAL |
| CREATIVE TESTING SOLUTIONS | ||
| A | $1,108,506 | ACCRUAL |
| CREATIVE TESTING SOLUTIONS | ||
| J | $1,554,338 | ACCRUAL |
| CREATIVE TESTING SOLUTIONS | ||
| C | $1,084,804 | ACCRUAL |
| CREATIVE TESTING SOLUTIONS | ||
| Q | $277,727 | ACCRUAL |
| CREATIVE TESTING SOLUTIONS | ||
| S | $6,500,000 | ACCRUAL |
| INLAND NORTHWEST BLOOD CENTER | ||
| H | $625,953 | ACCRUAL |
| INLAND NORTHWEST BLOOD CENTER | ||
| L | $1,639,318 | ACCRUAL |
| INLAND NORTHWEST BLOOD CENTER | ||
| Q | $92,563 | ACCRUAL |
| INLAND NORTHWEST BLOOD CENTER | ||
| P | $112,500 | ACCRUAL |
| INLAND NORTHWEST BLOOD CENTER | ||
| C | $83,204 | ACCRUAL |
| belle BONFILS memorial BLOOD CENTER | ||
| G | $128,718 | ACCRUAL |
| belle BONFILS memorial BLOOD CENTER | ||
| H | $614,634 | ACCRUAL |
| belle BONFILS memorial BLOOD CENTER | ||
| L | $1,435,429 | ACCRUAL |
| belle BONFILS memorial BLOOD CENTER | ||
| M | $127,599 | ACCRUAL |
| belle BONFILS memorial BLOOD CENTER | ||
| Q | $516,878 | ACCRUAL |
| belle BONFILS memorial BLOOD CENTER | ||
| C | $110,000 | ACCRUAL |
| BLOOD BANK OF SAN BERNARDINO & RIVERSIDE | ||
| G | $12,879,205 | ACCRUAL |
| BLOOD BANK OF SAN BERNARDINO & RIVERSIDE | ||
| H | $751,314 | ACCRUAL |
| BLOOD BANK OF SAN BERNARDINO & RIVERSIDE | ||
| L | $1,231,717 | ACCRUAL |
| BLOOD BANK OF SAN BERNARDINO & RIVERSIDE | ||
| Q | $476,017 | ACCRUAL |
| LIFESHARE community blood services | ||
| G | $1,464,268 | ACCRUAL |
| LIFESHARE community blood services | ||
| H | $116,542 | ACCRUAL |
| LIFESHARE community blood services | ||
| L | $464,350 | ACCRUAL |
| LIFESHARE community blood services | ||
| Q | $131,694 | ACCRUAL |
| LIFESHARE community blood services | ||
| C | $129,472 | ACCRUAL |
| BERGEN COMMUNITY REGIONAL BLOOD CENTER | ||
| G | $871,690 | ACCRUAL |
| BERGEN COMMUNITY REGIONAL BLOOD CENTER | ||
| L | $240,628 | ACCRUAL |
| BERGEN COMMUNITY REGIONAL BLOOD CENTER | ||
| Q | $131,493 | ACCRUAL |
| BERGEN COMMUNITY REGIONAL BLOOD CENTER | ||
| C | $234,504 | ACCRUAL |
| Mid-South Regional Blood CenteR INC | ||
| Q | $105,965 | ACCRUAL |
Comments